Biomarin Pharmaceutical Inc (BMRN)

Healthcare Pharmaceuticals & Medical Research Pharmaceuticals

Track

Stock chart

Ticker: BMRN Exchange: NSM

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings

Earnings

Value bought

Past 90 days

Value sold

Past 90 days

Net insiders buying

Past 90 days

Trades (buy and sell)

Past 90 days

Company data

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2025-03-20	2025-03-19	PS Planned sale	Burkhart Erin GVP, Chief Accounting Officer Officer	1,295 -7.1% 71.52 USD 92,618	1,295 -7.1%	71.52	USD 92,618
2025-03-07	2025-03-06	S Sale	Guyer Charles Greg EVP, Chief Technical Officer Officer	7,034 -7.4% 71.28 USD 501,355	7,034 -7.4%	71.28	USD 501,355
2025-02-25	2025-02-24	PS Planned sale	Burkhart Erin GVP, Chief Accounting Officer Officer	1,344 -9.3% 68.38 USD 91,903	1,344 -9.3%	68.38	USD 91,903
2024-11-14	2024-11-12	S Sale	Guyer Charles Greg EVP, Chief Technical Officer Officer	5,278 -7.1% 66.37 USD 350,324	5,278 -7.1%	66.37	USD 350,324
2024-08-15	2024-08-13	PS Planned sale	Burkhart Erin GVP, Chief Accounting Officer Officer	714 -4.7% 90.00 USD 64,260	714 -4.7%	90.00	USD 64,260
2024-05-31	2024-05-30	PS Planned sale	Mueller Brian EVP, Chief Financial Officer Officer	5,000 -6.5% 75.19 USD 375,950	5,000 -6.5%	75.19	USD 375,950
2024-05-30	2024-05-28	PS Planned sale	Davis George Eric EVP, Chief Legal Officer Officer	2,779 -4.7% 75.29 USD 209,225	2,779 -4.7%	75.29	USD 209,225
2024-05-30	2024-05-28	PS Planned sale	Davis George Eric EVP, Chief Legal Officer Officer	38,071 -39.2% 74.46 USD 2,834,576	38,071 -39.2%	74.46	USD 2,834,576
2024-05-13	2024-05-10	PS Planned sale	BIENAIME JEAN JACQUES Non-Executive Director	20,000 -4.0% 81.14 USD 1,622,800	20,000 -4.0%	81.14	USD 1,622,800
2024-05-13	2024-05-10	PS Planned sale	BIENAIME JEAN JACQUES Non-Executive Director	20,000 -4.0% 81.14 USD 1,622,800	20,000 -4.0%	81.14	USD 1,622,800
2024-05-13	2024-05-09	PS Planned sale	BIENAIME JEAN JACQUES Non-Executive Director	20,000 -4.0% 81.62 USD 1,632,400	20,000 -4.0%	81.62	USD 1,632,400
2024-05-13	2024-05-09	PS Planned sale	BIENAIME JEAN JACQUES Non-Executive Director	20,000 -4.0% 81.62 USD 1,632,400	20,000 -4.0%	81.62	USD 1,632,400
2024-05-06	2024-05-02	PS Planned sale	Ajer Jeffrey Robert EVP, Chief Commercial Officer Officer	5,000 -7.0% 82.91 USD 414,550	5,000 -7.0%	82.91	USD 414,550
2024-05-06	2024-05-02	PS Planned sale	Davis George Eric EVP, Chief Legal Officer Officer	1,850 -3.2% 85.01 USD 157,269	1,850 -3.2%	85.01	USD 157,269
2024-04-15	2024-04-12	PS Planned sale	BIENAIME JEAN JACQUES Non-Executive Director	20,000 -4.0% 91.26 USD 1,825,200	20,000 -4.0%	91.26	USD 1,825,200
2024-04-15	2024-04-11	PS Planned sale	BIENAIME JEAN JACQUES Non-Executive Director	20,000 -4.0% 90.99 USD 1,819,800	20,000 -4.0%	90.99	USD 1,819,800
2024-04-12	2024-04-10	PS Planned sale	Burkhart Erin GVP, Chief Accounting Officer Officer	2,286 -12.4% 90.00 USD 205,740	2,286 -12.4%	90.00	USD 205,740
2024-04-01	2024-03-28	PS Planned sale	Davis George Eric EVP, Chief Legal Officer Officer	24,602 -30.6% 88.34 USD 2,173,341	24,602 -30.6%	88.34	USD 2,173,341
2024-03-07	2024-03-06	S Sale	BIENAIME JEAN JACQUES Non-Executive Director	1,000 -0.2% 86.71 USD 86,713	1,000 -0.2%	86.71	USD 86,713
2024-03-07	2024-03-05	PS Planned sale	Ajer Jeffrey Robert EVP, Chief Commercial Officer Officer	4,000 -4.1% 87.07 USD 348,280	4,000 -4.1%	87.07	USD 348,280
2024-03-07	2024-03-05	S Sale	FUCHS HENRY J President, Worldwide R&D Officer	35,341 -14.3% 85.18 USD 3,010,396	35,341 -14.3%	85.18	USD 3,010,396
2024-03-07	2024-03-05	S Sale	BIENAIME JEAN JACQUES Non-Executive Director	1,000 -0.2% 85.51 USD 85,510	1,000 -0.2%	85.51	USD 85,510
2024-02-29	2024-02-27	S Sale	BIENAIME JEAN JACQUES Non-Executive Director	1,000 -0.2% 90.35 USD 90,350	1,000 -0.2%	90.35	USD 90,350
2024-02-12	2024-02-09	PS Planned sale	BIENAIME JEAN JACQUES Non-Executive Director	15,000 -3.5% 88.28 USD 1,324,200	15,000 -3.5%	88.28	USD 1,324,200
2024-02-12	2024-02-08	PS Planned sale	BIENAIME JEAN JACQUES Non-Executive Director	15,000 -3.5% 89.77 USD 1,346,550	15,000 -3.5%	89.77	USD 1,346,550
2024-01-11	2024-01-10	PS Planned sale	BIENAIME JEAN JACQUES Non-Executive Director	10,000 -2.3% 96.38 USD 963,800	10,000 -2.3%	96.38	USD 963,800
2024-01-11	2024-01-09	PS Planned sale	BIENAIME JEAN JACQUES Non-Executive Director	10,000 -2.3% 98.19 USD 981,900	10,000 -2.3%	98.19	USD 981,900
2023-12-22	2023-12-21	PS Planned sale	BIENAIME JEAN JACQUES Non-Executive Director	10,000 -2.3% 93.99 USD 939,900	10,000 -2.3%	93.99	USD 939,900
2023-12-14	2023-12-13	PS Planned sale	Davis George Eric EVP, Chief Legal Officer Officer	13,764 -19.8% 95.30 USD 1,311,709	13,764 -19.8%	95.30	USD 1,311,709
2023-08-17	2023-08-16	PS Planned sale	Ajer Jeffrey Robert EVP, Chief Commercial Officer Officer	5,000 -7.6% 90.00 USD 450,000	5,000 -7.6%	90.00	USD 450,000
2023-08-11	2023-08-10	S Sale	FUCHS HENRY J President, Worldwide R&D Officer	12,000 -6.4% 90.43 USD 1,085,111	12,000 -6.4%	90.43	USD 1,085,111
2023-08-10	2023-08-09	S Sale	Guyer Charles Greg EVP, Chief Technical Officer Officer	5,360 -11.8% 93.30 USD 500,109	5,360 -11.8%	93.30	USD 500,109
2023-08-09	2023-08-08	S Sale	BIENAIME JEAN JACQUES Chief Executive Officer Executive Director	6,000 -1.4% 88.29 USD 529,740	6,000 -1.4%	88.29	USD 529,740
2023-08-09	2023-08-08	S Sale	Davis George Eric EVP, Chief Legal Officer Officer	11,000 -13.7% 89.42 USD 983,662	11,000 -13.7%	89.42	USD 983,662
2023-08-09	2023-08-07	S Sale	BIENAIME JEAN JACQUES Chief Executive Officer Executive Director	4,000 -0.9% 88.10 USD 352,400	4,000 -0.9%	88.10	USD 352,400
2023-05-15	2023-05-11	PS Planned sale	BIENAIME JEAN JACQUES Chief Executive Officer Executive Director	5,561 -1.3% 95.22 USD 529,518	5,561 -1.3%	95.22	USD 529,518
2023-05-15	2023-05-11	PS Planned sale	BIENAIME JEAN JACQUES Chief Executive Officer Executive Director	24,439 -5.4% 94.55 USD 2,310,707	24,439 -5.4%	94.55	USD 2,310,707
2023-05-11	2023-05-10	PS Planned sale	BIENAIME JEAN JACQUES Chief Executive Officer Executive Director	8,547 -2.0% 95.34 USD 814,871	8,547 -2.0%	95.34	USD 814,871
2023-05-11	2023-05-10	PS Planned sale	BIENAIME JEAN JACQUES Chief Executive Officer Executive Director	21,453 -4.7% 94.65 USD 2,030,526	21,453 -4.7%	94.65	USD 2,030,526
2023-05-11	2023-05-09	PS Planned sale	BIENAIME JEAN JACQUES Chief Executive Officer Executive Director	1,410 -0.3% 95.90 USD 135,219	1,410 -0.3%	95.90	USD 135,219
2023-05-11	2023-05-09	PS Planned sale	BIENAIME JEAN JACQUES Chief Executive Officer Executive Director	14,964 -3.4% 95.49 USD 1,428,912	14,964 -3.4%	95.49	USD 1,428,912
2023-05-11	2023-05-09	PS Planned sale	BIENAIME JEAN JACQUES Chief Executive Officer Executive Director	13,626 -3.0% 94.22 USD 1,283,842	13,626 -3.0%	94.22	USD 1,283,842
2023-04-12	2023-04-10	PS Planned sale	BIENAIME JEAN JACQUES Chief Executive Officer Executive Director	10,000 -2.3% 99.56 USD 995,600	10,000 -2.3%	99.56	USD 995,600
2023-04-10	2023-04-06	PS Planned sale	BIENAIME JEAN JACQUES Chief Executive Officer Executive Director	10,000 -2.3% 96.13 USD 961,300	10,000 -2.3%	96.13	USD 961,300
2023-04-04	2023-04-03	PS Planned sale	LAWLIS V BRYAN Non-Executive Director	8,500 -22.7% 97.09 USD 825,265	8,500 -22.7%	97.09	USD 825,265
2023-03-14	2023-03-13	PS Planned sale	BIENAIME JEAN JACQUES Chief Executive Officer Executive Director	8,000 -1.6% 90.45 USD 723,600	8,000 -1.6%	90.45	USD 723,600
2023-03-14	2023-03-10	PS Planned sale	BIENAIME JEAN JACQUES Chief Executive Officer Executive Director	15,000 -3.0% 92.28 USD 1,384,200	15,000 -3.0%	92.28	USD 1,384,200
2023-02-14	2023-02-13	PS Planned sale	BIENAIME JEAN JACQUES Chief Executive Officer Executive Director	6,000 -1.8% 109.15 USD 654,900	6,000 -1.8%	109.15	USD 654,900
2023-02-14	2023-02-10	PS Planned sale	BIENAIME JEAN JACQUES Chief Executive Officer Executive Director	15,000 -4.5% 110.11 USD 1,651,650	15,000 -4.5%	110.11	USD 1,651,650
2023-01-27	2023-01-25	PS Planned sale	Ajer Jeffrey Robert EVP, Chief Commercial Officer Officer	4,175 -9.2% 116.15 USD 484,943	4,175 -9.2%	116.15	USD 484,943
2023-01-27	2023-01-25	PS Planned sale	Ajer Jeffrey Robert EVP, Chief Commercial Officer Officer	44,825 -49.8% 115.65 USD 5,184,191	44,825 -49.8%	115.65	USD 5,184,191
2023-01-18	2023-01-17	PS Planned sale	BIENAIME JEAN JACQUES Chief Executive Officer Executive Director	10,000 -3.0% 111.55 USD 1,115,500	10,000 -3.0%	111.55	USD 1,115,500
2023-01-18	2023-01-13	PS Planned sale	BIENAIME JEAN JACQUES Chief Executive Officer Executive Director	10,000 -3.0% 112.25 USD 1,122,500	10,000 -3.0%	112.25	USD 1,122,500
2023-01-17	2023-01-13	PS Planned sale	Mueller Brian EVP, Chief Financial Officer Officer	2,500 -8.3% 114.50 USD 286,250	2,500 -8.3%	114.50	USD 286,250
2022-12-15	2022-12-13	PS Planned sale	Mueller Brian EVP, Chief Financial Officer Officer	2,500 -8.3% 107.50 USD 268,750	2,500 -8.3%	107.50	USD 268,750
2022-12-15	2022-12-13	S Sale	BIENAIME JEAN JACQUES Chief Executive Officer Executive Director	1,000 -0.3% 106.89 USD 106,890	1,000 -0.3%	106.89	USD 106,890
2022-12-06	2022-12-02	S Sale	BIENAIME JEAN JACQUES Chief Executive Officer Executive Director	69 -0.0% 104.06 USD 7,180	69 -0.0%	104.06	USD 7,180
2022-12-06	2022-12-02	S Sale	BIENAIME JEAN JACQUES Chief Executive Officer Executive Director	100 -0.0% 104.00 USD 10,400	100 -0.0%	104.00	USD 10,400
2022-12-06	2022-12-02	S Sale	BIENAIME JEAN JACQUES Chief Executive Officer Executive Director	260 -0.1% 103.98 USD 27,035	260 -0.1%	103.98	USD 27,035
2022-12-06	2022-12-02	S Sale	BIENAIME JEAN JACQUES Chief Executive Officer Executive Director	600 -0.2% 103.97 USD 62,383	600 -0.2%	103.97	USD 62,383
2022-12-06	2022-12-02	S Sale	BIENAIME JEAN JACQUES Chief Executive Officer Executive Director	471 -0.1% 103.97 USD 48,970	471 -0.1%	103.97	USD 48,970
2022-12-06	2022-12-02	PS Planned sale	Mueller Brian EVP, Chief Financial Officer Officer	3,761 -11.9% 104.50 USD 393,025	3,761 -11.9%	104.50	USD 393,025
2022-12-06	2022-12-02	PS Planned sale	Mueller Brian EVP, Chief Financial Officer Officer	2,139 -7.2% 104.50 USD 223,526	2,139 -7.2%	104.50	USD 223,526
2022-12-06	2022-12-02	PS Planned sale	Mueller Brian EVP, Chief Financial Officer Officer	1,101 -3.8% 104.50 USD 115,055	1,101 -3.8%	104.50	USD 115,055
2022-11-28	2022-11-23	PS Planned sale	Mueller Brian EVP, Chief Financial Officer Officer	3,500 -10.8% 99.50 USD 348,250	3,500 -10.8%	99.50	USD 348,250
2022-11-28	2022-11-23	PS Planned sale	Mueller Brian EVP, Chief Financial Officer Officer	945 -3.2% 99.50 USD 94,028	945 -3.2%	99.50	USD 94,028
2022-11-28	2022-11-23	PS Planned sale	Mueller Brian EVP, Chief Financial Officer Officer	934 -3.0% 95.09 USD 88,814	934 -3.0%	95.09	USD 88,814
2022-11-04	2022-11-02	PS Planned sale	Ajer Jeffrey Robert EVP, Chief Commercial Officer Officer	3,000 -6.8% 86.12 USD 258,360	3,000 -6.8%	86.12	USD 258,360
2022-11-02	2022-10-31	B Purchase	Alles Mark J Non-Executive Director	3,625 +49.8% 86.75 USD 314,469	3,625 +49.8%	86.75	USD 314,469
2022-11-01	2022-10-31	S Sale	BIENAIME JEAN JACQUES Chief Executive Officer Executive Director	1,500 -0.5% 86.55 USD 129,825	1,500 -0.5%	86.55	USD 129,825
2022-10-18	2022-10-14	PS Planned sale	BIENAIME JEAN JACQUES Chief Executive Officer Executive Director	4,000 -1.2% 89.89 USD 359,560	4,000 -1.2%	89.89	USD 359,560
2022-08-16	2022-08-15	PS Planned sale	BIENAIME JEAN JACQUES Chief Executive Officer Executive Director	3,000 -0.9% 95.21 USD 285,630	3,000 -0.9%	95.21	USD 285,630
2022-08-16	2022-08-12	S Sale	BIENAIME JEAN JACQUES Chief Executive Officer Executive Director	4,000 -1.2% 94.75 USD 379,000	4,000 -1.2%	94.75	USD 379,000
2022-08-12	2022-08-11	PS Planned sale	Ajer Jeffrey Robert EVP, Chief Commercial Officer Officer	3,000 -6.4% 95.62 USD 286,860	3,000 -6.4%	95.62	USD 286,860
2022-08-11	2022-08-09	S Sale	Davis George Eric EVP, Chief Legal Officer Officer	47,526 -46.2% 95.93 USD 4,559,169	47,526 -46.2%	95.93	USD 4,559,169

Biomarin Pharmaceutical Inc (BMRN)

Track

Stock chart

Earnings

Value bought

Value sold

Net insiders buying

Trades (buy and sell)

Transactions

Insider

Sort by